Relmada Therapeutics Inc (RLMD)

$RLMD let's get big news

$RLMD old charts and one biotech analyst's advice, had they not screwed up the placebo arm on Relight he would have been conservative

$RLMD I'd say more like $1.80 is a good bell now. not much higher

$RLMD Main danger to the $RLMD shareholders is Sergio Traversa.

Make sure you have ticker SKYQ on ur watch! SKYQ is trading under book value and the chart is curling. September roadmap includes green infrastructure + digital asset strategy. No dilution risk makes this even better. SKYQ has the potential to go big, Fridays action shows something is brewing big. Be early and we all bank big. $RLMD $PMNT $LIMN $SMX watching.

$IXHL With a couple of dips in Share Price, hopefully we’ll see some stabilization and a confirmed level of support. We might not see some Recovery until some additional News about the $20M share buyback or another unexpected PR announcement. (stay strong longs) 💪 🔥 It’s been really intriguing to watch the consistent upward momentum of $FBIO over the last month or so, with a large pickup in momentum over the last week! There has been significant institutional buying of FBIO over the past several quarters, including both new positions and increases in existing stakes. The accumulated activity from these institutions reflects continued interest and confidence in the company. 👉 Overall institutional ownership remains high, with 96.5% of FBIO shares held by institutions and hedge funds. I am speculating here, but IF this momentum continues, we “could” see a rerate of the Share Price hitting anywhere between $7 and $12 before the highly anticipated catalyst this month! (maybe there’s something else brewing?) The FDA has set a PDUFA goal date of September 30, 2025 for CUTX‑101 👌😎 🔥 The Insider Buying for $RLMD speaks Volumes “to me”!!! 😲 Insider Buying Volume According to Barchart, over the past 3 months: 4 insider buys totaling 978,961 shares No insider sales reported In my experience, when Insiders start buying up shares, the Share Price starts to positively react! 👏 Insiders are presumed to have deep knowledge of the company and wouldn't buy if they expected the stock to fall. Confidence Signal: If multiple insiders buy at once (like with RLMD), it may suggest a coordinated belief that the company is undervalued or nearing a major milestone (e.g., trial data, partnership, or FDA action). I mention this because… 👇👇 Sergio Traversa, CEO of Relmada Therapeutics (RLMD), also just made open‑market share purchases totaling 265,976 shares across three days (August 26, 27, and 28, 2025). 3 BioTechs that should make things pretty damn exciting over the next 3-4 weeks! 🙏🥳 Not Buy/Sell advice… do some of your own Due Diligence on 1 or all 3 over Saturday/Sunday!! Have a great weekend all!! 🤙

$RLMD For anybody considering a swing trade vs a long hold, I picked this up on August 30 after insider buying info showing the CEO making buys on open market 3 days in a row. Along with the TA and the 91% efficacy of their bladder cancer drug. Remalda failed several phase 2 trials in a row. The stock was in danger of being listed this January from NASDAQ for failing to meet the minimum one dollar stock price. They have finally figured it out. They have something and they know it. There has been no insider selling only purchasing. It’s still holding 3 bd on the 1D chart 🔥🔥🔥🔥🔥🚀🚀🚀🚀🚀 HODL

$IXHL 📚 $RLMD 💥 Just bought some RLMD as well! (thanks for the tip) 😉 91% effectiveness without any AE’s is pretty damn solid for a Bladder Cancer treatment!! 👌😎👏 With additional positions to my Portfolio like RLMD, IXHL and $FBIO I am looking forward to next week and the end of September!!! 🥳💪 Happy Friday all!!! 🤙

$RLMD After the licensing agreement with Trigone for NDV-01 gel, stock price recovered a bit but still selling at an extremely deep Sergio Traversa/Key-Man/Conman discount. Just look at $CGON today, both are going after the same market but the NDV-01 gel shown much better efficacy so far. He burned and conned not only the shareholders but also analysts from reputable investment banks. That's why current stock price is $1.60 but analysts are keeping their average target price at $1.00. Dr. Raj Pruthi current CMO should lead the company. Trigone & Squadron Capital Management LLC should lead the Board.

$RLMD ***HUGE $1,000+ SOON*** THE CANCER CURE gonna be YUGE, INSIDERS LOADING THE BOAT, they know what's up!!! $$$ 100X BAGGER